Myriad (MYGN) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2023, Myriad Genetics (MYGN) reported revenue of $196.6 million, up 10.6% over the same period last year. EPS came in at$ 0.04, compared to - $0.12 in the year-ago quarter.The reported revenue represents a surprise of +1.17% over the Zacks Consensus Estimate of$ 194.33 million. With the consensus EPS estimate being $0.02, the EPS surprise was +100.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to det ...